Clinical Trials Browser

Liver, Cancer of, Primary Resectable × Doxorubicin × Clear all

NCT05701436 2023-03-02

Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Phase 3 Unknown

Liver, Cancer of, Primary Resectable